INCIDENCE AND RISK FACTORS FOR DRUG INDUCED HEPATOTOXICITY IN PULMONARY TB PATIENTS TAKING ATT ACCORDING TO DOTS

Akash Bhuriya; Vinod Kumar Singh

Volume : VII, Issue : III, March - 2017

INCIDENCE AND RISK FACTORS FOR DRUG INDUCED HEPATOTOXICITY IN PULMONARY TB PATIENTS TAKING ATT ACCORDING TO DOTS

Akash Bhuriya, Vinod Kumar Singh

Abstract :

INTRODUCTION: ABSTRACT: INTRODUCTION: Tuberculosis still remains a serious clinical problem. Out of standard first line drugs, rifampicin and pyrazinamide have been observed to have hepatotoxic potential & drug induced hepatotoxicity (DIH) is an important and commonly encountered adverse effect with anti TB treatment (2, 3) . A higher risk of hepatotoxicity has been reported in Indian patients(4–7) than in their western counterparts(7–9) .The reasons for the higher rate of hepatotoxicity in Indian patients are unclear. AIMS AND OBJECTIVES: 1. To study the incidence of hepatotoxicity in patients receiving antitubercular treatment(ATT) as per Revised National TuberculosisControlProgramme. 2. To know the possible risk factors for the development of drug induced hepatotoxicity. MATERIAL AND METHODS: In the prospective study, 100 freshly diagnosed pulmonary tuberculosis patients attending the medicine outpatient department or admitted in TMMC & RC, Moradabad and attending RNTCP DOTS center in the hospital were taken up for study. RESULTS: TWO patient (2%) developed ATT induced DIH which included cases in the age group of 41–60years both patients had pretreatments albumin <3.5% gm/dl & BMI<17.5% CONCLUSION: The incidence of asymptomatic elevation of liver enzymes secondary to ATT is 8% .Advanced age, BMI < 17.5, pretreatment hypoalbuminemia are predisposing factors for the development of ATT induced hepatotoxicity.